Developing an ecosystem for life sciences startups takes a lot of energy and support. The Innovation Commercialization Assistance Program (ICAP), a program of George Mason University and the Virginia SBDC, has been laying the groundwork to support these emerging companies and has tapped two new life sciences mentors to provide guidance for entrepreneurs.
Prince William County and VirginiaBio recently welcomed visitors to the new 33,000 square feet of wet lab space at the Northern Virginia BioScience Center, showcasing the county’s work toward becoming a life sciences hotspot.
Asian/Pacific American Heritage (AAPI) Month is celebrated annually during the month of May. It marks the celebration of Asians and Pacific Islanders in the United States.
Ceres Nanosciences, a Northern Virginia bioscience company spun out of George Mason University that specializes in diagnostic products and workflows, has opened a 12,000-square-foot advanced particle manufacturing plant in Prince William County’s Innovation Park.
A new 12,000-square-foot Advanced Particle Manufacturing Plant in Prince William County’s Innovation Park will allow Ceres Nanosciences to boost production of its Nanotrap particles technology.
In 2020 we introduced a new series titled “5 Questions With…” in an effort to spotlight individuals from across the BioHealth Capital Region and beyond. Providing this platform has allowed us to help share the stories of industry peers and show that there isn’t a single “right” way to becoming an industry success.
As Executive Director of the Institute for Biohealth Innovation at George Mason University, Amy Adams is responsible for nurturing and advancing biohealth research and innovation interests of more than 250 faculty and thousands of students who represent a broad range of academic disciplines. Her role includes fostering partnerships with industry, healthcare, government, and academic partners.
The 6th annual Biohealth Capital Region (BHCR) Forum kicks off on October 19th. This year’s event will be held virtually and will bring together the top biotech and life science executives and expert speakers from across the industry, academia, healthcare, government, finance, and real estate development, among others.
COVID-19 Vaccine Progress from 14 BioHealth Capital Region Companies
Q&A with Virginia (Ginny) Espina, PhD, MT(ASCP) Dr. Ginny Espina is a Research Associate Professor at George Mason University’s Center for Applied Proteomics and Molecular Medicine. She will be the [….]
